Your browser doesn't support javascript.
loading
Relapsed/Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphoma.
Maurer, Matthew J; Jakobsen, Lasse H; Mwangi, Raphael; Schmitz, Norbert; Farooq, Umar; Flowers, Cristopher R; de Nully Brown, Peter; Thompson, Carrie A; Frederiksen, Henrik; Cunningham, David; Jørgensen, Judit; Poeschel, Viola; Nowakowski, Grzegorz; Seymour, John F; Merli, Francesco; Haioun, Corinne; Ghesquieres, Hervé; Ziepert, Marita; Tilly, Hervé; Salles, Gilles; Shi, Qian; El-Galaly, Tarec C; Habermann, Thomas M.
Afiliação
  • Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Jakobsen LH; Aalborg University Hospital, Aalborg, Denmark.
  • Mwangi R; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Schmitz N; Department of Medicine A, University Hospital Münster, Münster, Germany.
  • Farooq U; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, Iowa.
  • Flowers CR; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, Texas.
  • de Nully Brown P; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Thompson CA; Division of Hematology, Mayo Clinic, Rochester, Minnosata.
  • Frederiksen H; Department of Hematology, Odense University Hospital, Odense, Denmark.
  • Cunningham D; Department of Medicine, Royal Marsden Hospital, Surrey, UK.
  • Jørgensen J; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Poeschel V; Saarland University Medical School, Homburg, Germany.
  • Nowakowski G; Division of Hematology, Mayo Clinic, Rochester, Minnosata.
  • Seymour JF; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Merli F; Hematology Unit, Azienda Unità Sanitaria Locale/IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Haioun C; Clinical Hematology, Henri Mondor University Hospital, UPEC, Creteil, France.
  • Ghesquieres H; Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France.
  • Ziepert M; Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, IMISE, Leipzig, Germany.
  • Tilly H; Centre Henri Becquerel, University of Rouen, Rouen, France.
  • Salles G; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Shi Q; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • El-Galaly TC; Aalborg University Hospital, Aalborg, Denmark.
  • Habermann TM; Division of Hematology, Mayo Clinic, Rochester, Minnosata.
Am J Hematol ; 96(5): 599-605, 2021 05 01.
Article em En | MEDLINE | ID: mdl-33661547
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Linfoma Difuso de Grandes Células B Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Linfoma Difuso de Grandes Células B Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article